Willow Biosciences, Inc. (WLLW) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

NexgenRx, Inc.

Neptune Digital Assets Corp.

Everyday People Financial Corp.

Willow Biosciences, Inc.

American Aires, Inc.

Personas Social, Inc.

EverGen Infrastructure Corp.

TDG Gold Corp.

SOL Global Investments Corp.

ASEP Medical Holdings, Inc.

NextGen Food Robotics Corp.

Why is Willow Biosciences, Inc. ?

Risky - Negative EBITDA

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -61.90%, its profits have risen by 52.5%

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -61.90% returns in the last 1 year, the stock has also underperformed S&P/TSX 60 in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Miscellaneous)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Willow Biosciences, Inc. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Willow Biosciences, Inc.

-61.9%

-0.11

568.76%

S&P/TSX 60

19.1%

1.35

14.39%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

41.44%

EBIT Growth (5y)

9.36%

EBIT to Interest (avg)

-14.71

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-1.33

Sales to Capital Employed (avg)

1.45

Tax Ratio

0.02%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

0.30%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

-0.72

EV to EBIT

-0.37

EV to EBITDA

-0.49

EV to Capital Employed

2.06

EV to Sales

0.44

PEG Ratio

Dividend Yield

ROCE (Latest)

-558.10%

ROE (Latest)

Negative BV

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

Bearish

No Signal

Bollinger Bands

Sideways

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Bullish

Bearish

Dow Theory

Mildly Bullish

OBV

No Trend

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

32What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CAD -2.01 MM

NET SALES(HY)

Higher at CAD 3.64 MM

OPERATING PROFIT(Q)

Highest at CAD -0 MM

NET PROFIT(Q)

Highest at CAD -0.32 MM

RAW MATERIAL COST(Y)

Fallen by -116.61% (YoY

INVENTORY TURNOVER RATIO(HY)

Highest at 9.53%

DEBTORS TURNOVER RATIO(HY)

Highest at 82.19%

PRE-TAX PROFIT(Q)

Highest at CAD -0.32 MM

EPS(Q)

Highest at CAD -0.01

-10What is not working for the Company

INTEREST(HY)

At CAD 0.2 MM has Grown at 101.02%

ROCE(HY)

Lowest at -971.43%

Here's what is working for Willow Biosciences, Inc.

Net Sales

At CAD 3.64 MM has Grown at 2,500.71%

Year on Year (YoY)

MOJO Watch

Sales trend is very positive

Net Sales (CAD MM)

Operating Cash Flow

Highest at CAD -2.01 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CAD MM)

Operating Profit

Highest at CAD -0 MM and Grown

In each period in the last five periods

MOJO Watch

Near term Operating Profit trend is quite positive

Operating Profit (CAD MM)

Net Profit

Highest at CAD -0.32 MM and Grown

In each period in the last five periods

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (CAD MM)

Net Sales

Higher at CAD 3.64 MM

than preceding 12 month period ended Mar 2025

MOJO Watch

In the half year the company has already crossed sales of the previous twelve months

Net Sales (CAD MM)

Pre-Tax Profit

Highest at CAD -0.32 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CAD MM)

Pre-Tax Profit

At CAD -0.32 MM has Grown at 79.5%

over average net sales of the previous four periods of CAD -1.55 MM

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CAD MM)

Net Profit

At CAD -0.32 MM has Grown at 79.51%

over average net sales of the previous four periods of CAD -1.55 MM

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CAD MM)

EPS

Highest at CAD -0.01

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (CAD)

Inventory Turnover Ratio

Highest at 9.53%

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Debtors Turnover Ratio

Highest at 82.19%

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost

Fallen by -116.61% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Willow Biosciences, Inc.

Interest

At CAD 0.2 MM has Grown at 101.02%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CAD MM)